Targeted breast cancer treatment approved for routine NHS use
By Liz Wells 11 April 2025
NICE is recommending capivasertib with fulvestrant to treat women with advanced breast cancer, which means the drug will be funded immediately through the Cancer Drugs Fund.
NHS offers 'new hope' for children with severe epilepsy
By Liz Wells 20 February 2025
Hundreds of children with severe epilepsy will be able to benefit from a groundbreaking new treatment on the NHS that could significantly reduce their seizures.
Director of Children’s Social Care and Early Help
£104,337 – £115,105
Oldham, Greater Manchester£104,337 – £115,105
Assistant Director – People Commissioning & Business Support
£96,350 – £108,925
Bradford, West Yorkshire£96,350 – £108,925
Director of Children’s Social Care and Early Help
£104,337 – £115,105
Oldham, Greater Manchester£104,337 – £115,105
Assistant Director – People Commissioning & Business Support
£96,350 – £108,925
Bradford, West Yorkshire£96,350 – £108,925
©2024 Hemming Group Limited. Registered in England and Wales. Registered No: 490200. VAT number GB342 023 408
